Riemenschneider, M. J., Fischer, J., Grassow-Narlik, M., Mawrin, C., Deimling, A. v., Pietsch, T., . . . Rothhammer-Hampl, T. (2020). Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019. Clinical neuropathology, 39(5), . https://doi.org/10.5414/NP301278
Chicago-Zitierstil (17. Ausg.)Riemenschneider, Markus Johannes, et al. "Quality Assurance in Neuropathology: Experiences from the Round Robin Trials on IDH Mutation and MGMT Promoter Methylation Testing Launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019." Clinical Neuropathology 39, no. 5 (2020). https://doi.org/10.5414/NP301278.
MLA-Zitierstil (9. Ausg.)Riemenschneider, Markus Johannes, et al. "Quality Assurance in Neuropathology: Experiences from the Round Robin Trials on IDH Mutation and MGMT Promoter Methylation Testing Launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019." Clinical Neuropathology, vol. 39, no. 5, 2020, https://doi.org/10.5414/NP301278.